Phathom Pharmaceuticals Inc — 四半期キャッシュフロー (NASDAQ:PHAT) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 378.32 M294.21 M250.22 M240.29 M259.15 M 負債合計 631.9 M632.58 M656.05 M662.82 M697.32 M 純資産合計 -253.58 M-338.38 M-405.83 M-422.53 M-438.17 M 負債および純資産合計 378.32 M294.21 M250.22 M240.29 M259.15 M 有利子負債合計 201.41 M203.25 M205.14 M207.09 M209.09 M 純負債 -95.85 M-9.07 M55.57 M71.94 M79.11 M

ニュース

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Guggenheim、収益予想上回りPhathom株の目標株価を25ドルに引き上げ

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifelが Phathom株のBuy評価を再表明、目標株価28ドルを維持

Stifel reiterates Buy on Phathom stock, keeps $28 price target

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates